DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology ...

Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024.

More than a decade after coining “Treat Yo’ Self Day” in her role as Donna on “Parks & Recreation,” Retta is once again ...

Canaccord Genuity analyst William Plovanic has maintained their bullish stance on DXCM stock, giving a Buy rating yesterday. William Plovanic has given his Buy rating due to a combination of ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

Unlike the company’s existing G7 CGM, Stelo is designed for adults 18+ who are not on insulin therapy. It’s aimed at the 25 million people with Type 2 diabetes and those with prediabetes.

I managed to lose seven pounds. SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced ...

The Dexcom Stelo Glucose Biosensor System is an integrated CGM intended for people 18 and older who do not use insulin. Stelo is a small, gray device worn on the upper arm, about the size of a ...

Dexcom CGM is being worn by astronauts in space as part of the Polaris Dawn mission, which aims to better understand the effects of spaceflight on human health SAN DIEGO, September 10, 2024 ...